|16th March 2018
The clinical value precision medicines promises is widely recognised as the future of healthcare, but the inherent complexity of introducing these treatments and incorporating them into clinical practice is challenging for both industry and academia.
On 14 March 2018, Senior Consultant David Cooney arrived in Dublin, Ireland, to talk to key industry players about some of the challenges experienced by those developing precision medicines.
He presented an enlightening speech on ‘Understanding the opportunity of precision medicine’ at The National Pharmaceutical & Life Sciences Expo, held at the Citywest Exhibition Centre.
The presentation set out the differences between personalised and precision medicine. Importantly, David focused on the commercial challenges and opportunities for those at the forefront of innovation.
"It was really inspiring to see how advanced Ireland is in precision medicine, and how many people are taking a design thinking approach to solving complex healthcare problems"
This included, making the business case for precision medicine and exploring how the industry can help support the implementation and adoption of these innovative treatments.
He also analysed important hot topics, including the role of big data in overcoming market access challenges and delivering better patient outcomes.
More than 1,000 senior managers from the pharmaceutical and life sciences industry attended the event, taking the opportunity to learn about the latest innovations in healthcare.
David said: “It was really inspiring to see how advanced Ireland is in precision medicine, and how many people are taking a design thinking approach to solving complex healthcare problems.”
To learn more about how we support our clients in launching innovative therapies, contact firstname.lastname@example.org